Lüscher, Thomas F.

Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy

Templin, C., Ghadri, J. R., Diekmann, J., Napp, L. C., Bataiosu, D. R., Jaguszewski, M., Cammann, V. L., Sarcon, A., Geyer, V., Neumann, C. A., et al. (2015) · New England Journal of Medicine

Takotsubo Cardiomyopathy and Associated PhenomenaPsychosomatic Disorders and Their Treatments

Cited by 2,595

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 2,083

The Aging Cardiovascular System

Paneni, F., Diaz Cañestro, C., Libby, P., Lüscher, T. F., & Camici, G. G. (2017) · Journal of the American College of Cardiology

Cardiovascular Health and Disease PreventionNitric Oxide and Endothelin Effects

Cited by 618

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

Besler, C., Heinrich, K., Rohrer, L., Doerries, C., Riwanto, M., Shih, D. M., Chroni, A., Yonekawa, K., Stein, S., Schaefer, N., et al. (2011) · Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsParaoxonase enzyme and polymorphisms

Cited by 535

Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors

Li, X. S., Obeid, S., Klingenberg, R., Gencer, B., Mach, F., Räber, L., Windecker, S., Rodondi, N., Nanchen, D., Muller, O., et al. (2017) · European Heart Journal

Gut microbiota and healthAcute Myocardial Infarction Research

Cited by 479

Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease: Role of High-Density Lipoprotein–Proteome Remodeling

Riwanto, M., Rohrer, L., Roschitzki, B., Besler, C., Mocharla, P., Mueller, M., Perisa, D., Heinrich, K., Altwegg, L., von Eckardstein, A., et al. (2013) · Circulation

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 337

Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2

Speer, T., Rohrer, L., Blyszczuk, P., Shroff, R., Kuschnerus, K., Kränkel, N., Kania, G., Zewinger, S., Akhmedov, A., Shi, Y., et al. (2013) · Immunity

Nitric Oxide and Endothelin EffectsAtherosclerosis and Cardiovascular Diseases

Cited by 310

Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy

Kraler, S., Blaser, M. C., Aikawa, E., Camici, G. G., & Lüscher, T. F. (2022) · European Heart Journal

Cardiac Valve Diseases and TreatmentsCardiac Imaging and Diagnostics

Cited by 281

Genetic deletion of p66 Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress

Camici, G. G., Schiavoni, M., Francia, P., Bachschmid, M., Martin-Padura, I., Hersberger, M., Tanner, F. C., Pelicci, P., Volpe, M., Anversa, P., et al. (2007) · Proceedings of the National Academy of Sciences

Nitric Oxide and Endothelin EffectsRedox biology and oxidative stress

Cited by 249

Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia.

Kaufmann, P. A., Gnecchi-Ruscone, T., Schäfers, K. P., Lüscher, T. F., & Camici, P. G. (2000) · Journal of the American College of Cardiology

Cardiac Imaging and DiagnosticsLipoproteins and Cardiovascular Health

Cited by 217

Tetrahydrobiopterin Improves Endothelial Function in Patients with Coronary Artery Disease

Maier, W., Cosentino, F., Lütolf, R. B., Fleisch, M., Seiler, C., Hess, O. M., Meier, B., & Lüscher, T. F. (2000) · Journal of Cardiovascular Pharmacology

Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention

Cited by 217

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J. J. F., Borén, J., Farnier, M., Ference, B. A., Gielen, S., Graham, I., et al. (2018) · European Heart Journal

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 200

Vulnerable plaques and patients: state-of-the-art

Tomaniak, M., Katagiri, Y., Modolo, R., de Silva, R., Khamis, R. Y., Bourantas, C. V., Torii, R., Wentzel, J. J., Gijsen, F. J. H., van Soest, G., et al. (2020) · European Heart Journal

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 197

A Novel Circulating Noncoding Small RNA for the Detection of Acute Myocarditis

Blanco-Domínguez, R., Sánchez-Díaz, R., de la Fuente, H., Jiménez-Borreguero, L. J., Matesanz-Marín, A., Relaño, M., Jiménez-Alejandre, R., Linillos-Pradillo, B., Tsilingiri, K., Martín-Mariscal, M. L., et al. (2021) · New England Journal of Medicine

Viral Infections and Immunology ResearchMicroRNA in disease regulation

Cited by 196

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Barbato, E., Azizi, M., Schmieder, R. E., Lauder, L., Böhm, M., Brouwers, S., Bruno, R. M., Dudek, D., Kahan, T., Kandzari, D. E., et al. (2023) · European Heart Journal

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 188

Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome

Ståhlberg, M., Reistam, U., Fedorowski, A., Villacorta, H., Horiuchi, Y., Bax, J., Pitt, B., Matskeplishvili, S., Lüscher, T. F., Weichert, I., et al. (2021) · The American Journal of Medicine

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 183

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration

Ference, B. A., Cannon, C. P., Landmesser, U., Lüscher, T. F., Catapano, A. L., & Ray, K. K. (2018) · European Heart Journal

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 161

Artificial intelligence in cardiovascular medicine: clinical applications

Lüscher, T. F., Wenzl, F. A., D’Ascenzo, F., Friedman, P. A., & Antoniades, C. (2024) · European Heart Journal

Artificial Intelligence in Healthcare and EducationArtificial Intelligence in Healthcare

Cited by 160

Myocarditis Following COVID-19 Vaccine: Incidence, Presentation, Diagnosis, Pathophysiology, Therapy, and Outcomes Put Into Perspective. A Clinical Consensus Document Supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases

Heidecker, B., Dagan, N., Balicer, R., Eriksson, U., Rosano, G., Coats, A., Tschöpe, C., Kelle, S., Poland, G. A., Frustaci, A., et al. (2022) · European Journal of Heart Failure

Viral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 Research

Cited by 159

The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression

Miranda, M. X., van Tits, L. J., Lohmann, C., Arsiwala, T., Winnik, S., Tailleux, A., Stein, S., Gomes, A. P., Suri, V., Ellis, J. L., et al. (2015) · European Heart Journal

Cholesterol and Lipid MetabolismSirtuins and Resveratrol in Medicine

Cited by 153

Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia

Cosentino, F., Hürlimann, D., Delli Gatti, C., Chenevard, R., Blau, N., Alp, N. J., Channon, K. M., Eto, M., Lerch, P., Enseleit, F., et al. (2008) · Heart

Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention

Cited by 143

Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial

Ruschitzka, F., Borer, J. S., Krum, H., Flammer, A. J., Yeomans, N. D., Libby, P., Lüscher, T. F., Solomon, D. H., Husni, M. E., Graham, D. Y., et al. (2017) · European Heart Journal

Inflammatory mediators and NSAID effectsBlood Pressure and Hypertension Studies

Cited by 130

SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory

Paneni, F., Volpe, M., Lüscher, T. F., & Cosentino, F. (2013) · Diabetes

Sirtuins and Resveratrol in MedicineAdvanced Glycation End Products research

Cited by 118

Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis

Blaser, M. C., Kraler, S., Lüscher, T. F., & Aikawa, E. (2021) · Circulation Research

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 109